We found indeed that hAMSC treatment constantly reduced the relative amount of B cells in alveolar spaces and lung expression of B220, a murine B‐cell marker, suggesting this as a possible mechanism of hAMSCs to contrast lung fibrosis. Here, PTPRC is linked to pulmonary fibrosis.